Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Cash & Equivalents (2024 - 2026)

Updated

Drugs Made In America Acquisition (DMAA) recorded Cash & Equivalents of $20,280 in Q2 2026, compared with $822.00 a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Drugs Made In America Acquisition reported Cash & Equivalents of $6,137, up 354.3% from FY2024.

  • Across earlier years, Cash & Equivalents came in at $1,351 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 10.49 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 2.51 Bn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 760.00 Mn
5 Kkr 81.05 Bn 47.53 Bn - 21.08 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 1.50 Bn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 26.82 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 100.19 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 1.01 Bn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 20,280.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,280.00
Dec 31, 2025 6,137.00
Sep 30, 2025 717.00
Jun 30, 2025 822.00
Mar 31, 2025 923.00
Dec 31, 2024 1,351.00
API Access

Drugs Made In America Acquisition Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DMAA&period=max&api_key=YOUR_API_KEY